SCHEDULE 13D

Company

NEKTAR THERAPEUTICS

Filed

August 22, 2005

Accession Number

0001193125-05-172419

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →